| Aegis Therapeutics and Roche Enter Into a License Agreement for ProTek(R) Stabilization
December 1, 2009 at 12:01 am
|
| SAN DIEGO, CA--(Marketwire - December 1, 2009) - Aegis Therapeutics LLC (Aegis) announced today that they have signed a License Agreement providing Roche access to Aegis' proprietary ProTek® stabilization technology. The ProTek® technology covers the use of specific excipients as stabilizers in certain manufacturing processes and formulations of protein-based therapeutics. Under the terms of the agreement, Aegis will receive undisclosed up-front licensing fees and individual product-related event and royalty payments. |
| UPDATE: Radient Pharma Completes Registered Direct Offering for Approximately $1 Million
November 30, 2009 at 10:35 pm
|
| TUSTIN, CA--(Marketwire - November 30, 2009) - US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million." The press release originally stated the amount of the placement agent fees associated with the stated registered direct offering. As the exclusive placement agent for the transaction, Jesup & Lamont Securities Corporation will receive a cash fee equal to 6% of the gross proceeds of the offering, a non-accountable expense allowance equal to (a) 2% of the gross proceeds of the offering less (b) the actual amount of accountable expenses paid to or on behalf of Jesup & Lamont on or prior to the closing, and will receive warrants equal to 2% of the shares of common stock purchased by the investor |
| Scrubs & Beyond Partners With Thanx Media to Improve Scrubs Online Search
November 30, 2009 at 10:32 pm
|
| BRENTWOOD, MO--(Marketwire - November 30, 2009) - A quick visit to Scrubs & Beyond's website and you will see that there have been some changes. Scrubs & Beyond went to Thanx Media for help in creating a new and improved website search engine. They partnered with Thanx Media to add their market leading search technology, Endeca On-Demand Express, to the Scrubs & Beyond website. This powerful search tool was developed by Thanx to improve user interaction with e-commerce websites by making it even easier to find whatever you are looking for, be it Dickies medical uniforms, uniform scrubs or anything in between. |
| Riverside Medical Center Ranks in National Study
November 30, 2009 at 10:24 pm
|
| KANKAKEE, IL--(Marketwire - November 30, 2009) - In the areas of joint replacement, orthopedic surgery, spine surgery and stroke treatment, Riverside Medical Center was the recipient of several Specialty Excellence awards, making it one of the top hospitals in Illinois. From 2006 to 2008 HealthGrades, the administrator of the ranking, took on the daunting annual task of reading and analyzing the outcomes of over 40 million Medicare hospital records from over 5,000 hospitals across the United States. Of note, no given hospital can decline being rated and HealthGrades charges nothing for its ratings process, giving an impartial assessment of hospitals in the United States. Since the risk profiles of patients from hospital to hospital are not alone, the ranking system risk-adjusts the data, permitting for more accurate and fair comparisons. |
| Radient Pharma Completes Registered Direct Offering for Approximately $1 Million
November 30, 2009 at 5:30 pm
|
| TUSTIN, CA--(Marketwire - November 30, 2009) - US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today it has entered into definitive agreements to sell an aggregate of 3,289,472 shares of its common stock at a price per share of $0.28 pursuant to a registered direct offering to institutional investors, resulting in gross proceeds of approximately $1 million. Investors will receive warrants to purchase up to 1,644,736 shares of Radient Pharmaceutical Corporation common stock. The warrants have an initial exercise price of $1.25 per share and are exercisable at any time on or after 6 months and prior to the six and one-half year anniversary of the initial issuance date. |
| NexgenRx Announces 2009 Third Quarter Results
November 30, 2009 at 4:50 pm
|
| | TORONTO, ONTARIO--(Marketwire - Nov. 30, 2009) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") is pleased to announce its 2009 third quarter results. Revenue from transaction fees for the three months ended September 30, 2009, of $682,022, represented an increase of $17,164 over the same period in the prior year. The net loss for the three months ended September 30, 2009 was $537,200 ($0.01 per common share), compared with a loss of $632,394 ($0.02 per common share) for the same period in the prior year. |
| Medicure Announces Further Agreement With Secured Lender
November 30, 2009 at 3:45 pm
|
| WINNIPEG, MANITOBA--(Marketwire - Nov. 30, 2009) - Medicure Inc. ("Medicure" or the "Company") (TSX:MPH) today announced it has reached agreement with the lender under its secured debt financing agreement dated September 17, 2007 to a further deferral of required payments of approximately US$2.0M until December 14, 2009. The agreement allows the Company to continue its discussions with the lender regarding its payment obligations, and to explore restructuring and/or financing strategies. About Medicure Inc. Medicure Inc is a biopharmaceutical company focused on the research, development and commercialization of novel small molecules to treat cardiovascular and neurological disorders. The Company's primary business activity is the marketing and distribution of AGGRASTAT® (tirofiban hydrochlori |
| Hydromer, Inc. Sells Medical OEM Business to Forefront Medical
November 30, 2009 at 3:39 pm
|
| BRANCHBURG, NJ--(Marketwire - November 30, 2009) - Hydromer, Inc. (OTCBB: HYDI) announces the sale of its Private Label Jejunostomy Catheter and Nasogastric Feeding Catheter business to Forefront Medical Technologies. Forefront Medical Technologies is a wholly owned subsidiary of Vicplas International Limited, a company registered in the Republic of Singapore. Under the terms of this agreement Forefront Medical Technologies ("Forefront") will pay US$800,000 in cash to Hydromer, Inc.'s wholly owned subsidiary Biosearch Medical Products, Inc. ("Biosearch"). $400,000 was payable upon the effective date and the second $400,000 is held in escrow until the transition is complete. The agreement also calls for Biosearch to assign certain customer supply agreements to Forefront and for a 3 year non-compete provision. Biosearch will continue to manufacture these products during the transition at an agreed upon transfer pr |
| New Web Site Fills in the Missing Pieces That May Be Hindering Recovery From Depression
November 30, 2009 at 3:30 pm
|
| Interactive Depression Tool Provides Information People Need |
| Radient Pharmaceuticals Reschedules Third Quarter 2009 Earnings Conference Call to Thursday December 3, 2009
November 30, 2009 at 3:00 pm
|
| TUSTIN, CA--(Marketwire - November 30, 2009) - Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company that specializes in In Vitro Diagnostic (IVD) cancer tests and cell-renewing skin care products, today announced that, due to requirements related to the Company's registered direct finance offering and shareholder requests, it has changed the date of its previously announced third quarter earnings results conference call from Monday, November 30, 2009 to Thursday, December 3, 2009. |
| Ophthalmic Imaging Systems Receives FDA Clearance to Market Revolutionary New Portable Digital Imaging Device
November 30, 2009 at 2:59 pm
|
| SACRAMENTO, CA--(Marketwire - November 30, 2009) - Ophthalmic Imaging Systems ("OIS" or "the Company") (OTCBB: OISI), a leading digital imaging and informatics company, today announced that its revolutionary new portable imaging device, the OIS EyeScan, has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The OIS EyeScan is the only portable imaging device that is capable of imaging both the anterior and posterior segment of the eye. Powered by OIS WinStation Software, and fully integrated with the OIS Symphony Image Management Solution, OIS EyeScan will deliver more functionality than has ever been available in an imaging device. With the ability to capture images from a customized chin rest, from a slit lamp adapter or as a handheld device, the OIS EyeScan is versatile enough to add value to any ophthalmologist's practice. The OIS EyeScan has been designed to be small enough to |
| COBRA Subsidy Extension: Can Short-Term Insurance Bridge the Gap?
November 30, 2009 at 1:48 pm
|
| eHealthInsurance Answers Frequently Asked Questions From Customers About Short-Term Insurance and the COBRA Subsidy |
| ProMutual Group's CME Website Expands Offerings
November 30, 2009 at 12:45 pm
|
| New ACCME Accredited Risk Management CMEs for Physicians Nationwide Available From Leading Medical Liability Insurer |
| Dearborn National(TM) Launches Dental Wellness Program
November 30, 2009 at 9:30 am
|
| CHICAGO, IL--(Marketwire - November 30, 2009) - Dearborn NationalT recently launched a proactive Dental Wellness Program to all of its dental members identified as at-risk for dental disease. "Unfortunately, many people don't take the basic steps that have been proven to prevent Periodontal Disease and tooth decay," said Tony Trani, president of Dearborn National, which features the largest dental PPO network in the United States with more than 146,000 access points. "We want to help our members understand both the importance of and the necessary steps involved in maintaining good oral health." |
| Novo Nordisk A/S: Transaction in Own Shares
November 30, 2009 at 9:19 am
|
| BAGSVAERD, DENMARK--(Marketwire - November 30, 2009) - Novo Nordisk A/S - Share repurchase programme On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009. Since the announcement as of 23 November 2009, the following transactions have been made under the programme: |
| Dupuytren's and Carpal Tunnel Specialist Dr. Evan Collins of The Methodist Hospital System Sought for New Percutaneous Needle Aponeurotomy (NA) Procedure
November 30, 2009 at 9:00 am
|
| Offered by Only a Small Group of Hand Specialists Throughout the United States, the NA Procedure Prompts Response to Collins' Less Invasive Treatment Options for Two of Today's Most Common Hand & Upper Extremity Conditions |
| Houston Veteran's Disability Attorney Marc Whitehead Assists Those Who Served Our Country
November 30, 2009 at 9:00 am
|
| HOUSTON, TX--(Marketwire - November 30, 2009) - Houston attorney Marc Whitehead is personally committed to assisting men and women faced with Veteran's disability claims. Each year, thousands of veterans who have served in our country's military services suffer from service-connected disabilities. Some are physical in nature, but post-traumatic stress disorder, or PTSD, is taking on greater proportions in disability claims. The frightening aspect of this disorder is that while many veterans who served in Iraq and Afghanistan will seek treatment immediately after their involvement in a traumatic event, many Vietnam veterans are just recognizing the symptoms for the first time. |
| TLCVision Listing Review Initiated by the Toronto Stock Exchange
November 30, 2009 at 9:00 am
|
| ST. LOUIS, MO--(Marketwire - November 30, 2009) - TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC), North America's premier eye care services company, today announced that it has been notified by the Toronto Stock Exchange ("TSX") that based on the Company's financial condition the TSX is reviewing the eligibility for continued listing on the TSX of the Company's common shares. The Company is being reviewed under the TSX's Remedial Review Process and has been granted 30 days to comply with all requirements for continued listing. If the Company cannot demonstrate that it meets all TSX requirements for continued listing on or before December 30, 2009, the Company's common shares will be delisted 30 days from such date. |
| NVIDIA, Siemens Healthcare Take Immersive 3D From the Movie Theater Into the Doctor's Office
November 30, 2009 at 9:00 am
|
| Medical Professionals, Expecting Parents Can See Fetus in Unprecedented Detail With 3D Ultrasound Technology and NVIDIA 3D Vision Glasses |
| ADSC Gains Extraordinary PACS Capabilities With CDP
November 30, 2009 at 9:00 am
|
| MAYWOOD, NJ--(Marketwire - November 30, 2009) - Advanced Data Systems Corporation (ADS), a leader in Radiology information systems with its MedicsRIS for Radiology is proud to announce its partnership with CDP Medical for leading edge PACS solutions. David Barzillai, President of ADS, said, "Our MedicsRIS solutions for Radiology are comprehensive, mature, stable and proven. We wanted to identify a RIS/PACS source possessing those same qualities as a suitable complement to our MedicsRIS, and we found it in CDP." |
| RSNA News: New Tool for Radiologists and Imaging Centers: LungPoint Procedure Planning Revolutionizes Referrals to Chest Physicians
November 30, 2009 at 9:00 am
|
| System Uses CT Scans to Enhance Planning for Bronchoscopic Procedures |
| INFINITT Earns No. 1 Ranking for Community PACS in 2009 KLAS Report
November 30, 2009 at 9:00 am
|
| INFINITT PACS Named KLAS 2009 Leader - Community Hospitals, 1-200 Beds |
| DALSA's Rad-icon Imaging Division Introduces the Helios10 MD 20 x 25 cm Panel for Medical Imaging
November 30, 2009 at 8:26 am
|
| CHICAGO, IL--(Marketwire - November 30, 2009) - RSNA 2009 - Booth # 7117 -- DALSA Corporation (TSX: DSA), through its Rad-icon Imaging division, today announced general availability of the Helios10 MD panel, the first product in the company's new Helios camera family. With an active area of 20 x 25 cm, the Helios10 MD is the first CMOS X-Ray panel from DALSA of this size and form factor, a medical-grade cassette package with an integrated handle. The Helios10 MD panel was designed to exceed the rigorous imaging requirements for a wide variety of medical imaging applications such as full-field digital mammography, general radiography, bone densitometry, and other mobile digital radiography (DR) applications. DALSA will be showcasing the Helios10 MD at RSNA 2009, the annual meetin |
| DALSA Introduces PC-Based, Real-Time Digital Image Processor Board for X-ray Imaging
November 30, 2009 at 8:23 am
|
| XRI-1600 Ideal for Demanding X-ray Instrumentation and Radioscopy Applications |
| Payton & Associates Attorney Anthony Victor De Yurre Honored by Cystic Fibrosis Foundation South Florida
November 30, 2009 at 8:00 am
|
| MIAMI, FL--(Marketwire - November 30, 2009) - Payton & Associates, LLC is pleased to announce that Anthony Victor De Yurre has been selected by the Cystic Fibrosis Foundation as one of "40 Under 40" outstanding lawyers of Miami-Dade County who are committed to helping the community and dedicated to providing outstanding legal service. Mr. De Yurre was honored at an event on November 20, 2009 at the Intercontinental Hotel in Miami, Florida. |
| Health Insurance Sites: eHealthInsurance Named to Kiplinger's Best List Third Year in a Row
November 30, 2009 at 8:00 am
|
| eHealthInsurance.com Is 2009 Best Insurance Site for Health Insurance Quotes |
| Acsys Interactive President Provides Recommendations to FDA Regarding Use of Social Media in Healthcare Industry
November 30, 2009 at 7:15 am
|
| FDA Seeks Policy Guidance Regarding the Promotion of Prescription Drugs, Biologics and Medical Devices Using the Internet and Social Media Tools |
| Van Andel Institute Phase II Expansion Project Prepares for Grand Opening
November 30, 2009 at 7:11 am
|
| GRAND RAPIDS, MI--(Marketwire - November 30, 2009) - Hunt Construction Group along with joint venture partner, Owen-Aimes-Kimball, prepare for a ribbon cutting ceremony on December 8th, 2009 at the Van Andel Institute's Phase II Expansion project. This marks the end of a fast paced construction schedule lasting more than two years. The project was completed two months ahead of schedule and within budget. |
| Medipattern and Sentinelle Medical Inc. Announce Breast MRI Development Partnership
November 30, 2009 at 6:30 am
|
| TORONTO, ONTARIO--(Marketwire - Nov. 30, 2009) - Attention: Business/Financial Editors The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity and Sentinelle Medical Inc., a leading manufacturer of magnetic resonance imaging (MRI) coils and advanced visualization software, have announced that they are entering a technology access and distribution agreement. Medipattern pioneered breast ultrasound computer aided detection (CAD) and leveraged this experience towards the development of powerful breast lesion MRI morphological analysis technology. Under the agreement, Sentinelle would gain exclusive license to Medipattern's breast MRI morphological analysis technology. |
| TeraRecon Highlights the Rapid Adoption of iNtuition at RSNA 2009
November 30, 2009 at 1:11 am
|
| CHICAGO, IL--(Marketwire - November 30, 2009) - TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuitionT advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL. Testimonials from some of the hundreds of customers who have selected iNtuition are provided below. | | | 
|
没有评论:
发表评论